If you’ve ever spotted a small shiny bump on your nose that just won’t heal, you know how unsettling it can be to wonder whether it’s something to worry about. Basal cell carcinoma (BCC) is the most common skin cancer in the US, and its visual progression—from a harmless-looking pearly nodule to an advanced ulcerating lesion—follows a recognizable path that dermatologists see every day.

4 related posts

Most Common Skin Cancer: 80% of non-melanoma cases · Primary Location: Face and neck · Growth Rate: Slow, rarely metastasizes · Detection Method: Visual exam by dermatologist · Warning Signs Count: Five key features

Quick snapshot

1Confirmed facts
2What’s unclear
  • Exact progression timelines vary by individual and subtype
  • Some aggressive BCC subtypes may advance faster than typical slow-growth patterns
3Timeline signal
  • BCC grows slowly at less than 1 mm per month, yet if left untreated, can progress over months to years (PMC NCBI)
  • Nasal BCC study: average 1.8 Mohs stages needed to clear margins (PMC NCBI)
4What’s next
  • Early detection makes the difference: Stage 0–2 BCC has a 95%+ cure rate when caught early
  • Mohs micrographic surgery (for face/nose) achieves high clearance rates with tissue-preserving precision

The key facts table below summarizes the essential attributes of basal cell carcinoma for quick reference.

Attribute Value Source
Cancer Type Non-melanoma skin cancer Healthline
Prevalence Over 3.6 million US cases yearly American Academy of Dermatology
Common Sites Face (nose, cheeks), neck, ears Skin Cancer Foundation
Risk Factors UV exposure, fair skin Cancer Therapy Advisor
Treatment Success 95%+ cure rate if early Moffitt Cancer Center

What does stage 1 basal cell cancer look like?

Stage 1 BCC marks the earliest point where a tumor becomes measurable. At this phase, the lesion is still small and confined to the skin’s surface, making it highly treatable. Dermatologists often describe these early growths as the “pearly nodule”—a round, raised bump with a shiny, translucent quality that catches light differently than surrounding skin. According to the American Academy of Dermatology (professional dermatology association), on lighter skin tones, this appears as a firm, raised, round growth that’s pink or reddish, while on darker skin it may show as a brown, black, or skin-colored bump. The edges often have fine blood vessels called telangiectasia running through them.

Early Appearance

  • Pearly or waxy bump: The classic early sign—a small, smooth elevation that may appear almost translucent at the edges
  • Translucent edges: Looking closely, you may see fine blood vessels visible through the lesion
  • Rarely painful: Early BCC typically doesn’t hurt, which is why it can go unnoticed

Common Pictures

The American College of Mohs Surgery (specialized surgical oncology institution) notes that BCC on the nose often starts as this pearly bump, frequently mistaken for a stubborn pimple or a healing cut. What separates it from a : it doesn’t resolve. The nodule persists, may bleed easily when touched or washed, and gradually becomes more noticeable over weeks to months. When examining pictures of Stage 1 BCC on the nose, look for that characteristic shiny surface and defined border against otherwise normal-appearing skin.

The upshot

Stage 1 BCC tumors are ≤2 cm in size, according to the Moffitt Cancer Center (NCI-designated comprehensive cancer center). At this size, treatment is straightforward and typically involves a simple office procedure with cure rates exceeding 95%.

What is Stage 2 basal cell carcinoma?

Stage 2 represents the middle ground—still localized and non-metastatic, but larger and potentially more complex to treat. The defining threshold is a tumor size between 2 and 4 centimeters, as documented by Cancer Therapy Advisor (clinical reference resource). At this stage, the lesion may develop high-risk features such as deeper invasion into the dermis or even perineural invasion, where cancer cells wrap around nerves. The visual appearance becomes more varied: the pearly nodule may develop a central depression or ulcerate, crusted areas may appear, and the overall border becomes less defined.

Growth Characteristics

  • Larger lesion diameter: Measuring 2–4 cm across, roughly the size of a dime to a quarter
  • Central depression or ulceration: The center may dimple inward or develop a crusted sore that bleeds
  • Irregular border: The edges become less smooth, spreading into surrounding skin

Visual Examples

A study of 321 nasal BCC patients (mean age 74.8 years) found that the most common presentation was solitary lesions (182 cases), followed by morpheic subtypes (79 cases) that appear as scar-like patches and behave more aggressively, according to research published in PMC NCBI (peer-reviewed medical research database). The morpheic variant, in particular, tends to be flatter and firmer, making it easy to dismiss as harmless—yet it carries higher recurrence risk. Pictures of Stage 2 BCC on the face typically show a lesion that has grown noticeably beyond the initial bump, often with visible crusting or a crater-like center that bleeds with minimal provocation.

What to watch

Perineural invasion—found in 56 of 321 nasal BCC cases in the PMC study—means cancer cells have reached nerves. This doesn’t show up in photos but requires special surgical attention. When a BCC is larger than 2 cm or located near the nose, ask your dermatologist specifically about nerve involvement before treatment.

When to worry about basal cell carcinoma?

Not every pimple-like bump is BCC, but certain signs should prompt a dermatologist visit. The Skin Cancer Foundation (patient education nonprofit) identifies five warning signs that differentiate BCC from benign growths. The most concerning is an open sore that bleeds, oozes, or crusts repeatedly and doesn’t heal within three to four weeks. Another red flag is any spot that grows, changes color, or develops new symptoms like itching or bleeding. On the face and neck—especially the nose—any persistent lesion that bleeds when you wash your face deserves professional attention.

Warning Signs

  • Non-healing sore: A patch that crusts over, bleeds, and re-opens repeatedly for more than four weeks
  • Rapid changes: Any growth that’s noticeably enlarging, darkening, or developing irregular borders
  • Bleeding with minimal contact: Lesions that bleed when gently touched or during routine face washing

Picture Comparisons

When comparing early BCC to benign skin conditions, the key distinction is persistence. A pimple resolves in days to a week or two. A bug bite fades within two weeks. BCC doesn’t fade—it stays and typically grows. The Healthline (health information platform) notes that superficial spreading BCC on the nose appears as thin, scaly, raised plaques that can resemble eczema or psoriasis, making professional diagnosis essential. Looking at pictures, early BCC typically has a more defined, rolled border and that characteristic translucent sheen, whereas benign spots usually blend more gradually into surrounding skin.

The catch

BCC grows slowly—less than 1 mm per month—but that slow pace lulls people into waiting. The MK Aesthetics (clinical practice) notes that neglected BCC can erode facial structures like the nose, ears, and even the orbital bones around eyes. By the time symptoms become severe, reconstruction becomes far more involved than early treatment would have required.

How do you know if you have advanced basal cell carcinoma?

Advanced BCC represents Stage 3 and Stage 4 disease—the point where tumors have grown significantly and may invade surrounding structures or even spread to distant sites. Stage 3 tumors exceed 4 cm and may penetrate bone, muscle, or cartilage, or involve a single lymph node, according to Moffitt Cancer Center. Stage 4, the most severe form, shows distant metastasis to lymph nodes, bones, or organs—a rare occurrence but one that can be devastating when it happens. The visual progression from early to advanced BCC is stark: what started as a small shiny bump becomes a large, crusted, ulcerating growth that may bleed profusely and cause significant facial disfigurement if left untreated for years.

Advanced Features

  • Large ulcerated lesion: A crater-like wound that doesn’t heal, often with raised, rolled borders
  • Deep tissue involvement: The growth penetrates through skin into underlying cartilage or bone
  • Facial structure changes: Particularly on the nose, you may see actual deformation or collapse of nasal architecture

Picture Gallery

Advanced BCC pictures reveal the consequences of long-term neglect. According to Cancer Therapy Advisor, advanced lesions show crusted, large growths with open, bleeding sores that become increasingly destructive. On the nose specifically, images show how the tumor can eat away at nasal cartilage, creating visible deformities that require extensive reconstructive surgery. A nasal BCC study documented aggressive subtypes including infiltrative and morpheaform patterns that present higher stage risk and require more extensive intervention. The key visual difference between Stage 1 and advanced BCC is profound: what begins as a smooth, small nodule transforms into an ugly, bleeding mass that can span several centimeters and deeply infiltrate facial structures.

What are the five warning signs of basal cell carcinoma?

The Skin Cancer Foundation (patient education nonprofit) publishes the five cardinal signs that should prompt you to see a dermatologist. First, an open sore that bleeds, oozes, crusts, or remains open for more than four weeks—often the most recognizable sign. Second, a reddish patch or irritated area, particularly on the face, neck, or ears, that may itch or cause discomfort but doesn’t resolve. Third, a shiny bump or nodule, often pearly or skin-colored, that may have visible blood vessels running through it. Fourth, a pinkish growth with slightly raised, rolled edges and a crusted indentation in the center. Fifth, a scar-like area that’s white, yellow, or waxy with poorly defined borders—this may indicate a morpheaform BCC subtype, which is particularly aggressive and can be difficult to detect.

Key Signs List

  • Open sore: Bleeds/oozes/crusts repeatedly, doesn’t heal after 4+ weeks
  • Reddish patch: Irritated area on face/neck/ears that may itch
  • Pearly bump: Shiny nodule, often with visible fine blood vessels (telangiectasia)
  • Pinkish growth: Raised rolled edges with central crusting or indentation
  • Scar-like patch: White/yellow/waxy area with fuzzy borders—may indicate aggressive subtype

Illustrated Examples

The American Academy of Dermatology (professional dermatology association) provides picture galleries showing how these warning signs appear across different skin tones—critical because BCC can look quite different depending on your baseline skin color. On lighter skin, BCC typically appears pink, red, or pearly-white. On darker skin, BCC may present as brown, black, or bluish patches that can resemble moles or other pigmented lesions. These galleries include photos of BCC on the nose, cheeks, and other facial areas, demonstrating the range of appearances. Notably, their images were last updated in October 2025, ensuring current clinical accuracy. Pictures show BCC appearing as persistent sores, scabs, and raised bumps that don’t resolve—contrasting with common benign conditions that typically heal within two weeks.

Why this matters

According to the Cancer Research UK (cancer research charity), most BCCs never need formal staging because the cancer rarely spreads. This means your dermatologist diagnoses and treats based on visual appearance and tumor characteristics—no need for extensive imaging or biopsies in most cases. The treatment decision hinges entirely on size, location, and subtype, not on whether distant metastasis has occurred.

What we know and what remains uncertain

Basal cell carcinoma is highly treatable when caught early, and the medical community has a clear picture of how it progresses in most cases. BCC rarely metastasizes—staging is uncommon unless tumors exceed 2 mm in depth or show aggressive features, according to the Moffitt Cancer Center. Visual diagnosis remains the cornerstone of detection, with dermatologists trained to recognize the characteristic shiny bump, rolled border, and telangiectasia. The growth rate is typically slow, under 1 mm per month, though aggressive subtypes like morpheaform and infiltrative BCC can advance more rapidly.

Confirmed

  • BCC rarely metastasizes (under 0.1% of cases)
  • Visual diagnosis by dermatologist is the primary detection method
  • Slow local growth pattern dominates, with aggressive subtypes being the exception
  • Early stages (0–2) are highly curable with >95% success rates
  • Mohs micrographic surgery provides the highest cure rates for facial BCC

Unclear

  • Exact progression timelines vary by individual and BCC subtype
  • Whether specific skin tones affect progression speed remains underexplored in research
  • Personal resistance factors and immune status may influence individual trajectories

What the experts say

“A firm, raised, round growth that’s shiny and pink or red is often a sign of basal cell carcinoma on lighter skin tones.”

— Natalie Matthews, MD, MPhil, FAAD, board-certified dermatologist with the American Academy of Dermatology

“BCCs of the nose are common. Only 3D-controlled micrographic surgery (Mohs or slow Mohs) guarantee a high rate of complete tumour removal and a very low risk of recurrence.”

— Research team, peer-reviewed medical research published in PMC NCBI

“Early basal cell carcinoma (Stage 0, Stage 1, and Stage 2) usually can be cured with appropriate treatment.”

— Clinical reference, Cancer Therapy Advisor

For anyone who spots a suspicious lesion on their face, the path forward is clear: get it checked by a dermatologist, ideally one with experience in skin cancer detection. The visual guide above shows that BCC doesn’t hide—it presents itself in recognizable patterns that trained eyes identify quickly. What may look like a harmless pimple or a stubborn cut is often the earliest stage of the most common skin cancer in the United States. The American Academy of Dermatology provides picture galleries that help patients compare their concerns against documented examples. For those with lesions on the nose specifically, the RxList (clinical reference) offers images showing how BCC typically presents in this high-risk location—often starting as a smooth, pearly nodule with visible telangiectasia that bleeds easily.

Bottom line: Basal cell carcinoma follows a predictable visual progression from a small pearly bump to advanced ulcerating lesions, but that progression takes years—giving patients ample window for early detection. Early BCC (≤2 cm) is highly curable (>95% cure rate); advanced BCC requires extensive reconstruction. For patients on the face and nose, Mohs micrographic surgery offers the highest clearance rates with tissue-sparing precision. If you see a persistent spot that doesn’t heal within three to four weeks, get it examined: that small bump might be the first visible sign of the most common skin cancer in the US.

Related reading: Do Eyelashes Grow Back? Timelines If Pulled or Cut · Fifth Ave Family Practice Tauranga: GP Services, Hours & Fees

These basal cell carcinoma stages pictures vividly capture progression that mirrors symptoms stages and early signs often overlooked in everyday skin checks.

Don't miss these

Frequently asked questions

Where is the most common place to get basal cell carcinoma?

The face—particularly the nose, cheeks, and around the eyes—is the most common site for BCC. The neck, ears, and scalp also see high rates. These areas receive the most cumulative sun exposure over a lifetime, and the skin there is often thinner and more delicate. BCC on the nose is especially common because the nose sits front-and-center on the face, receives significant UV exposure, and has thin skin over cartilage with less subcutaneous tissue for defense. According to a study of 321 nasal BCC patients (mean age 74.8 years), the nose represents a high-risk location due to its proximity to vital structures like the eyes.

How long does it take basal cell carcinoma to get serious?

BCC grows slowly—typically less than 1 mm per month. However, the rate varies by subtype. Nodular BCC, the most common type, progresses predictably over months to years. Morpheaform and infiltrative BCC subtypes are more aggressive and can advance faster. An untreated BCC that starts as a small pearly nodule can progress to an ulcerated, invasive lesion over 2–5 years in many cases, though the timeline depends heavily on individual factors like immune status, sun exposure, and tumor subtype. The key point: “slow” doesn’t mean “safe”—early treatment is always simpler and more effective.

What does advanced basal cell carcinoma look like?

Advanced BCC (Stage 3–4) shows as a large, ulcerated, crusted growth that bleeds easily, often exceeding 4 cm in diameter. The lesion develops raised, rolled borders with a central crater that may ooze or crust. On the nose, advanced BCC can visibly destroy nasal cartilage, creating deformities. The growth may penetrate deep into underlying bone or muscle, and the surrounding skin shows signs of inflammation and tissue damage. Pictures show these lesions as multi-centimeter, ugly, bleeding masses that bear no resemblance to the small pearly bump that likely started the cancer years earlier.

What are pictures of basal cell carcinoma on the nose?

Pictures of nasal BCC typically show a small, shiny, pearly bump with visible blood vessels (telangiectasia) running through it—this is the classic early presentation. As it progresses, the images show central depression or ulceration, crusting, and an enlarging nodule that bleeds when touched. On darker skin tones, the same lesion may appear brown, black, or skin-colored rather than pink or red. The American Academy of Dermatology provides gallery images showing these variations across skin tones. Advanced nasal BCC pictures show significant tissue destruction and visible deformity of the nose structure.

How does untreated basal cell carcinoma look after 2 years?

After two years of neglect, a BCC that started as a small pearly nodule typically progresses to a visible ulcerated lesion. The growth would likely have enlarged from its initial size to a diameter of several centimeters, developed a crusted central area that bleeds repeatedly, and shown irregular borders spreading into surrounding skin. On the nose specifically, two years of untreated BCC can lead to cartilage erosion and visible structural changes. The Mohs Surgeon UK notes that persistent sores, scabs, and crusted spots on the face are common presentations of neglected BCC.

What do non-melanoma basal cell carcinoma stages show?

The stages of non-melanoma BCC range from Stage 0 (carcinoma in situ, confined to the epidermis) through Stage 4 (distant metastasis). Stage 0 appears as a small flat scaly patch or red spot. Stage 1 shows a tumor ≤2 cm with no spread. Stage 2 shows a tumor 2–4 cm with possible high-risk features. Stage 3 shows a tumor >4 cm invading bone, muscle, or a single lymph node. Stage 4 shows distant metastasis to bones, organs, or distant lymph nodes. Most BCCs don’t require formal staging because metastasis is rare, but the AJCC TNM system is applied when high-risk features are present.

Are there photos of basal cell carcinoma on different skin tones?

Yes. The American Academy of Dermatology provides picture galleries showing BCC across a range of skin tones. On lighter skin, BCC typically appears as pink, red, or pearly-white lesions. On darker skin, BCC may present as firm, round, raised growths that are brown, black, or skin-colored—sometimes resembling moles or other pigmented lesions. The AIM at Skin Cancer Canada also provides regional variations showing small elevated bumps with red, pink, or pearly coloring. Recognizing BCC on darker skin requires looking for raised, firm nodules rather than relying on the red-pink signs commonly emphasized for lighter skin.